FOXL2 interacts with steroidogenic factor-1 (SF-1) and represses SF-1-induced CYP17 transcription in granulosa cells

Mira Park1, Eunkyoung Shin, Miae Won

  • 1Department of Biomedical Science, College of Life Science, CHA University, Seongnam 463-836, Korea.

Insights

Mutations in FOXL2 cause blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) and ovarian failure. This study reveals FOXL2 normally inhibits SF-1

Area of Science:

  • Reproductive Biology
  • Endocrinology
  • Genetics

Background:

  • Mutations in the FOXL2 gene are linked to blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) type I, characterized by premature ovarian failure in affected women.
  • FOXL2 plays a crucial role in ovarian granulosa cell development and function during folliculogenesis, as evidenced by defects in FOXL2-null mice.

Purpose of the Study:

  • To identify proteins interacting with FOXL2 in ovarian cells.
  • To elucidate the regulatory mechanism of FOXL2 on steroidogenesis, particularly concerning the CYP17 gene.
  • To investigate how FOXL2 mutations associated with BPES type I affect its interaction with SF-1 and regulation of CYP17.

Main Methods:

  • Screening of a rat ovarian yeast two-hybrid cDNA library to identify FOXL2-interacting proteins.
  • Co-immunoprecipitation assays to confirm the interaction between human FOXL2 and SF-1 in human granulosa cells.
  • Reporter gene assays to assess the regulation of CYP17 transcriptional activation by FOXL2 and SF-1.
  • Chromatin immunoprecipitation (ChIP) and Electrophoretic Mobility Shift Assay (EMSA) to analyze protein-DNA interactions at the CYP17 promoter.

Main Results:

  • Steroidogenic factor-1 (SF-1) was identified as a FOXL2-interacting protein.
  • FOXL2 negatively regulates SF-1-mediated transcriptional activation of the CYP17 gene in human granulosa cells.
  • FOXL2 mutants associated with BPES type I lose the ability to repress SF-1-induced CYP17 expression.
  • FOXL2 directly inhibits the binding of SF-1 to the CYP17 promoter, a function impaired in BPES-associated mutants.

Conclusions:

  • This study identifies a novel role for FOXL2 in negatively regulating the expression of the key steroidogenic enzyme CYP17 via interaction with SF-1.
  • Impaired inhibition of SF-1 binding to the CYP17 promoter by FOXL2 mutants provides a molecular mechanism for ovarian dysfunction in BPES type I.
  • FOXL2's regulation of CYP17 is critical for normal ovarian follicle development and function.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...